Welcome to our dedicated page for Livento Group SEC filings (Ticker: NUGND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Livento Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Livento Group's regulatory disclosures and financial reporting.
Livento Group, Inc., formerly NuGene International, Inc., is implementing a 1-for-20,000 reverse stock split of its common stock. Every 20,000 pre-split shares will automatically convert into one share. According to FINRA’s notice, pre-split shares of 4,339,753,594 will become 216,988 post-split shares.
The corporate action became effective on December 30, 2025, with the interim trading symbol NUGND. The stock is expected to begin trading on a split-adjusted basis under the new symbol LIVG when OTC Markets opens for trading on January 29, 2026. The reverse split does not change the authorized share count, par value, or voting rights.
No fractional shares will be issued. For most holders, any fractional share will be rounded up to the next whole share, while shares under the Equity Incentive Plan will be rounded down. Book-entry and brokerage holders will see their positions adjusted automatically through the transfer agent and intermediaries.
Livento Group, Inc. effected a 1-for-20,000 reverse stock split of its common stock, following prior stockholder approval of a reverse split at a ratio of not more than 1-for-20,000. Pre-split shares of common stock totaled 4,339,753,594 and post-split shares total 216,988.
The action is accompanied by a name and symbol change from NuGene International, Inc. (NUGN) to LIVENTO GROUP INC, with the temporary symbol NUGND and an expected transition to “LIVG” after 20 business days. Trading on a split-adjusted basis is expected to begin January 29, 2026.
The reverse split does not change the authorized share count, par value, or voting rights. No fractional shares will be issued; most fractional positions are rounded up to the next whole share, while shares under the Equity Incentive Plan are rounded down.
Livento Group, Inc. is implementing a major 1-for-20,000 reverse stock split of its common stock following prior stockholder approval and board authorization. The split was made effective with Delaware on December 30, 2025, and the company’s shares began trading on a split-adjusted basis under the temporary symbol NUGND on that date, with a further symbol change to LIVG expected on January 28, 2026. According to FINRA’s notice, pre-split shares of 4,339,753,594 were consolidated into 216,988 post-split shares, with a new CUSIP of 67052F201. The company’s name has been changed to LIVENTO GROUP INC, while the authorized share count, par value, and voting rights remain unchanged.
No fractional shares will be issued; most fractional positions will be rounded up to the next whole share, while shares under the Equity Incentive Plan will be rounded down. The company’s transfer agent, Equity Stock Transfer LLC, will handle the exchange, and stockholders holding in street name or book-entry form are not required to take action for their holdings to reflect the reverse split.
Livento Group, Inc. insider reports large share holdings. A Form 4/A filed for a single reporting person, who is both a director and 10% owner of Livento Group, Inc. (ticker NUGN), amends an earlier filing related to a transaction dated 01/14/2026. After the reported activity, the insider beneficially owns 100,139,152 common shares and 2,000,000 Preferred C shares, all held directly. The amendment notes the original was filed on 01/16/2026 and is signed by Michael Gregory Max Henriksen.
Livento Group, Inc. insider holdings disclosed
Livento Group, Inc. insider Henriksen Michael Gregory Max, identified as a 10% owner, reported his beneficial ownership of company equity as of January 14, 2026. The filing shows direct ownership of 100,139,152 Common Shares and 200,000,000 Preferred C Shares following the reported position. The form is filed for one reporting person and does not show any specific share acquisition or disposal codes, indicating it reflects reported holdings rather than a new purchase or sale.
Livento Group, Inc. is implementing a 1-for-20,000 reverse stock split of its common stock, effective January 28, 2026. Every 20,000 pre-split shares will automatically be combined into one post-split share, with no change to the total number of shares authorized, the par value, or the voting rights of the common stock.
The stock is expected to begin trading on a split-adjusted basis on OTC Markets on January 28, 2026 under a new symbol, LIVG, with a new CUSIP number. No fractional shares will be issued; most fractional positions will be rounded up to the next whole share, except for shares under the Equity Incentive Plan, which will be rounded down. The company’s transfer agent will handle the exchange electronically, and most shareholders will not need to take action.
A holder of the issuer’s common stock has filed a notice of proposed sale under Rule 144 to sell 100,000,000 common shares through Fidelity Investments on the OTC Markets, with an approximate sale date of 01/14/2026 and an aggregate market value listed as $1,900,000,000. The table states that 120,207,050 shares of this class are outstanding.
The securities to be sold were acquired as a purchase from Livento Group dated 09/28/2023, with an amount of 100,000,000 shares and payment by wire on 09/18/2023. The signer represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.